Sandoz has partnered with Samsung Bioepis to broaden patient access to high-quality biosimilar medicines worldwide. The ...

A recent FDA approval means consumers now have two GLP-1 weight loss pills to choose from as an alternative to the ...

Barbara is a tech writer specializing in AI and emerging technologies. With a background as a systems librarian in software development, she brings a unique perspective to her reporting. Having lived ...

Sandoz has struck a deal with Samsung Bioepis to partner on up to five biosimilars, with the first being SB36, a copycat of Takeda’s Entyvio (vedolizumab), which is being developed by the South ...

The weight you lose and the nausea you experience from GLP-1 drugs may be linked to common gene variants, but they can’t ...

Turbocharger use is more prolific than ever, and understanding how one works explains why it’s such a popular choice. To understand the benefit of a turbo, we need a refresher on the basics of the ...

Clinical trials suggest orforglipron will be comparable in effectiveness to oral semaglutide (the Wegovy pill). Of patients ...

Patients may be able to use the injections to actually lose weight, and then lean on the tablets to keep it off. The pills ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

The agreement covers up to five assets, including SB36, a biosimilar candidate referencing Entyvio (vedolizumab), for collaboration of development and commercialization in global markets excluding ...

GLP-1 weight-loss drug Wegovy has a lower, flat monthly price for patients who use a new subscription program for the ...

Adaptogens are popular plant and fungi compounds, but the science on their effectiveness and safety is still evolving.